Search - tctmd.com

Displaying 41 - 60 of 74

Sort: Relevancy | Date

Presentation TCT 2015

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

Presenter: Robert A. Byrne, Stefan K. James, Wojtek Wojakowski

October 11, 2015

$The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond$

Presentation TCT 2015

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein

October 11, 2015

Presentation TCT 2015

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso

October 11, 2015

Presentation TCT 2015

How Was the Case Treated

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2015

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani

October 11, 2015

Presentation TCT 2015

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Presenter: Robert A. Byrne, Stefan K. James

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Presenter: Stephen G. Ellis, John A. Ormiston, Robert A. Byrne

October 11, 2015

Presentation TCT 2014

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati

September 15, 2014

Presentation TCT 2014

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul

September 15, 2014

Presentation TCT 2014

BioFreedom: From Pilot Results to the Leaders-Free Trial

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban

September 15, 2014

Presentation TCT 2014

Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca

September 15, 2014

Presentation TCT 2014

The Drug-Filled Stent: From Concept to Clinical Development

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman

September 15, 2014

Presentation TCT 2014

Pro Bioabsorbable Polymer-Based Metallic DES!

Presenter: Robert A. Byrne

September 15, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Azeem Latib

September 13, 2014

Presentation TCT 2014

DCB Plus Adjunctive Stenting: Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Jochen Wöhrle

September 13, 2014

Presentation TCT 2014

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Raban Jeger

September 13, 2014

Advertisement

Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis

The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

How Was the Case Treated

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

BioFreedom: From Pilot Results to the Leaders-Free Trial

Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions

The Drug-Filled Stent: From Concept to Clinical Development

Pro Bioabsorbable Polymer-Based Metallic DES!

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Approach to In-Stent Restenosis in 2014: DCB or DES?

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

DCB Plus Adjunctive Stenting: Technique and Clinical Results

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content